Data / Form D filings / Triana Biomedicines, Inc.
Triana Biomedicines, Inc.: Form D filings
Triana Biomedicines, Inc., a pharmaceuticals company in Lexington, MA, filed 5 Form D notices with the SEC between 2020 and 2025. The latest, on December 4, 2025, reports $120.1 million sold of a $120.1 million offering to 20 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1050 WALTHAM STREET, SUITE 301, Lexington, MA, 02421
- Phone
- (781) 317-4414
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1815337
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 4, 2025 | New notice | $120,061,960 | $120,061,960 | 20 | Nov 26, 2025 | sec.gov | |
| Apr 19, 2022 | Amendment | $85,100,014 | $42,550,007 | $42,550,007 | 14 | Jan 28, 2022 | sec.gov |
| Feb 11, 2022 | New notice | $80,000,016 | $34,800,008 | $45,200,008 | 12 | Jan 28, 2022 | sec.gov |
| Sep 17, 2021 | New notice | $10,000,000 | $10,000,000 | 1 | Sep 3, 2021 | sec.gov | |
| Jul 6, 2020 | New notice | $14,000,000 | $6,000,000 | $8,000,000 | 3 | May 22, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Patrick Trojer | Executive Officer, Director | |
| Joshua Resnick | Director | |
| Jigar Raythatha | Director | |
| David Grayzel | Director | |
| Andrew Hedin | Director | |
| Lorence Kim | Director | |
| Shelley Chu | Director | |
| Christopher O'Donnell | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Dec 1, 2025 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Triana Biomedicines, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.